Harnessing the power of the immune system in cancer immunotherapy and cancer prevention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Harnessing the power of the immune system in cancer immunotherapy and cancer prevention

Published:2020-05-09 Issue:7 Volume:59 Page:675-678
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Lu Yong‐Chen¹^ORCID,Wang Xiao‐Jing²³

Affiliation:

1. Surgery Branch, National Cancer Institute, National Institutes of HealthBethesda Maryland

2. Department of PathologyUniversity of Colorado Anschutz Medical CampusAurora Colorado

3. Veterans Affairs Medical Center, VA Eastern Colorado Health Care SystemAurora Colorado

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23211

Reference28 articles.

1. Cancer Immunotherapy

2. Cancer immunotherapy using checkpoint blockade

3. CAR T cell immunotherapy for human cancer

4. Acquired Resistance to Immune Checkpoint Inhibitors

5. T‐cell receptor affinity in the age of cancer immunotherapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor-T (CAR-T) Cells as “Living Drugs”: A Clinical Pharmacist Perspective;Journal of Clinical Pharmacy and Therapeutics;2024-01-31

2. Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy;Cancer Immunology Research;2024-01-22

3. Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy;Advanced Materials;2023-04-02

4. Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy;2023-01-27

5. Neoantigen: A New Breakthrough in Tumor Immunotherapy;Frontiers in Immunology;2021-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3